Using a new MRI technique to diagnose lung lesions
The Application of the New Magnetic Resonance Technique-UTE in Thoracic Lesions
This study is testing a new MRI technique to see if it can help doctors tell the difference between harmless and harmful lung lesions in patients with larger lung issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fifth Affiliated Hospital, Sun Yat-Sen University Academic / other |
| Locations | 1 site (Zhuhai, Guangdong) |
| Trial ID | NCT05998707 on ClinicalTrials.gov |
What this trial studies
This study utilizes an ultrashort echo time (UTE) MRI technique to obtain quantitative characteristics of lung lesions, aiming to differentiate between benign and malignant conditions. By leveraging high-resolution zero echo time (ZTE) technology, the research seeks to enhance the diagnostic capabilities of MRI for pulmonary diseases, providing clearer images than conventional methods. The study focuses on patients with lung lesions that are at least 6mm in size and evaluates the feasibility of this advanced imaging approach in clinical settings.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with lung lesions measuring 6mm or more.
Not a fit: Patients with metal implants in the chest, MRI contrast agent allergies, or those who are pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the accuracy of lung lesion diagnoses, leading to better treatment decisions for patients.
How similar studies have performed: Previous studies have shown promising results using similar MRI techniques for evaluating lung conditions, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years old; 2. There are lung lesions, and the solid component is ≥6mm; 3. Chest CT plain scan or /+ enhanced examination within 4 weeks. Exclusion Criteria: 1. There are metal implants in the corresponding parts of the chest; 2. MRI contrast agent allergy; 3. Claustrophobia; 4. Pregnant women; 5. High fever; 6. Respiratory failure; 7. Lung lesion biopsy within 4 weeks prior to examination.
Where this trial is running
Zhuhai, Guangdong
- Radiography department — Zhuhai, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Xiaojun Chen
- Email: 422175400@qq.com
- Phone: +8615820587112
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.